Clinical Indication

Fibrosing interstitial lung diseases


In line with NICE TA747.

Implementation date 17th February 2022.

Date of classification

February 2022


Medicines which should be prescribed only in a specialist setting usually within a secondary or tertiary care service. NB: Some highly specialised RED medicines e.g. injectable treatments for cancer are not included on the LLR APC website list.